Homocysteine (Hct) is a substance produced in the metabolism of methionine. It is an
essential type of amino acid gained from the daily diet. Methylenetetrahydrofolate reductase …

Until the 1990s, venous thromboembolism (VTE) was viewed primarily as a complication of
hospitalization for major surgery (or associated with the late stage of terminal illness) …

Background The use of anticoagulant therapy during pregnancy is challenging because of
the potential for both fetal and maternal complications. This guideline focuses on the …

The risk factors for venous thrombosis differ from those for arterial vascular disease. During
the past 5 years, knowledge about the aetiology of venous thrombosis has advanced with …

An elevated level of total homocysteine (tHcy) in blood, denoted hyperhomocysteinemia, is
emerging as a prevalent and strong risk factor for atherosclerotic vascular disease in the …

In 1969, McCully made the clinical observation linking elevated plasma homocyst (e) ine
concentrations with vascular disease. 1 He reported autopsy evidence of extensive arterial …

ContextIn observational studies, elevated plasma total homocysteine levels have been
positively associated with ischemic stroke risk. However the utility of homocysteine-lowering …

Background Elevated plasma homocysteine levels are a risk factor for coronary heart
disease, but the prognostic value of homocysteine levels in patients with established …

BACKGROUND/AIMS: Portal vein thrombosis in patients with liver cirrhosis is usually
associated to hepatocellular carcinoma. Clinical presentation of non-neoplastic portal vein …

This article discusses the management of venous thromboembolism (VTE) and
thrombophilia, as well as the use of antithrombotic agents, during pregnancy and is part of …